Scheidegger M
Department of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich and University of Zurich, Switzerland.
ArticleAyahuasca
N,N-Dimethyltryptamine and harmine formulation alters transient EEG topography sequences near the peak of the psychedelic state.
ArticlePsychedelics
Salvinorin A in humans: A systematic review of pharmacokinetics, pharmacodynamics, and safety.
ArticleDMT
Combined DMT-harmine formulation reduces negative self-referential emotions during social self-evaluation: a randomized placebo-controlled trial in healthy volunteers.
ArticlePsilocybin
Global increases in brain glucose metabolism following acute N,N-dimethyltryptamine and harmine administration in healthy volunteers: A randomized [<sup>18</sup>F]FDG-PET study.
ArticleAyahuasca
Mixed-methods analysis on psychedelic-augmented meditation experiences from a randomized controlled mindfulness retreat.
PreprintAyahuasca
N, N-Dimethyltryptamine and harmine formulation shifts metastable topography sequences in the cortex
ArticlePsilocybin
Meditation, psychedelics, and brain connectivity: A randomized controlled resting-state fMRI study of <i>N,N</i>-dimethyltryptamine and harmine in a meditation retreat.
ArticleAyahuasca
Ayahuasca-inspired DMT/harmine formulation alters creative thinking dynamics during artistic creation.
PreprintPsilocybin
Meditation, Psychedelics, and Brain Connectivity: A Randomised Controlled Resting-State fMRI Study of <i>N,N</i>-Dimethyltryptamine and Harmine in a Meditation Retreat
PreprintPsilocybin
Global Increases in Brain Glucose Metabolism Following Acute N,N-Dimethyltryptamine and Harmine Administration in Healthy Volunteers: An [¹⁸F]FDG-PET Study
ArticleAyahuasca
Population pharmacokinetic-pharmacodynamic modeling of co-administered N,N-dimethyltryptamine and harmine in healthy subjects.
ArticleAyahuasca
Enhancing mindfulness and compassion through an ayahuasca-inspired formulation containing N,N-DMT and harmine: A randomized controlled trial in healthy subjects.
ArticleAyahuasca
Ayahuasca-inspired DMT/HAR formulation reduces brain differentiation between self and other faces.
ArticleAyahuasca
Examining the pharmacokinetic and pharmacodynamic interaction of N,N-dimethyltryptamine and harmine in healthy volunteers: Α factorial dose-escalation study.
ArticleAyahuasca
Pharmacokinetics and pharmacodynamics of an innovative psychedelic N,N-dimethyltryptamine/harmine formulation in healthy participants: a randomized controlled trial.
ArticleAyahuasca
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors
PreprintAyahuasca
Ayahuasca-Inspired DMT/HAR Formulation Reduces Brain Differentiation Between Self and Other Faces
ArticleDMT
Meditating on psychedelics. A randomized placebo-controlled study of DMT and harmine in a mindfulness retreat.
ArticleAyahuasca
Neurobiological research on N,N-dimethyltryptamine (DMT) and its potentiation by monoamine oxidase (MAO) inhibition: from ayahuasca to synthetic combinations of DMT and MAO inhibitors.
ArticlePsilocybin
Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditation.
ArticleAyahuasca
Potential therapeutic effects of an ayahuasca-inspired N,N-DMT and harmine formulation: a controlled trial in healthy subjects.
ArticleAyahuasca
Overcoming the clinical challenges of traditional ayahuasca: a first-in-human trial exploring novel routes of administration of N,N-Dimethyltryptamine and harmine.
ArticleLSD
The effects of Lysergic Acid Diethylamide (LSD) on the Positive Valence Systems: A Research Domain Criteria (RDoC)-Informed Systematic Review.
ArticleDMT
A pilot study of cerebral metabolism and serotonin 5-HT<sub>2A</sub> receptor occupancy in rats treated with the psychedelic tryptamine DMT in conjunction with the MAO inhibitor harmine.
ArticlePsychedelics
Not in the drug, not in the brain: Causality in psychedelic experiences from an enactive perspective.
ArticleAyahuasca
Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey.
ArticlePsychedelics
Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics.
ArticlePsilocybin